Presidio Partners
Presidio Partners is a San Francisco–based venture investment firm that emphasizes active portfolio management and company-building across information technology, life sciences, and energy technology. The firm leverages 25+ years of venture and operating experience (formerly as CMEA Capital), a data-and-technology orientation, and practices intended to increase transparency and accountability (for example, assigning two Presidio team members to each major investment).
Industries
Nr. of Employees
small (1-50)
Portfolio
Press items on product launches, patents, and a $33M Series D funding round noted on Presidio site.
#Life Sciences / Agricultural biotechnology
Noted on the site: completion of acquisition of Spitfire Pharma and development milestone toward a single-dose intranasal COVID-19 vaccine.
#Biotechnology / Vaccines
Press items reference executive team announcements and capital raises ($23M and $40M funding rounds reported in news items).
#Energy technology / Solar
A123 Systems completed a $5M equity investment (Series B) and Wildcat later raised over $20M in Series C financing according to Presidio content.
#Energy technology / Advanced materials for batteries
Multiple news items reference Series C financing, loan facility, patent issuance, and FDA approvals for products.
#Pharmaceuticals
Press items on product launches, patents, and a $33M Series D funding round noted on Presidio site.
#Life Sciences / Agricultural biotechnology
Noted on the site: completion of acquisition of Spitfire Pharma and development milestone toward a single-dose intranasal COVID-19 vaccine.
#Biotechnology / Vaccines
Press items reference executive team announcements and capital raises ($23M and $40M funding rounds reported in news items).
#Energy technology / Solar
A123 Systems completed a $5M equity investment (Series B) and Wildcat later raised over $20M in Series C financing according to Presidio content.
#Energy technology / Advanced materials for batteries
Multiple news items reference Series C financing, loan facility, patent issuance, and FDA approvals for products.
#Pharmaceuticals